Key figures
Ireland’s Central Statistics Office reported that modified domestic demand increased by 0.6% in the first quarter compared with the prior three months, while gross domestic product fell by 12.1% over the same period.
The reported GDP decline was substantially larger than the preliminary estimate, which had suggested a 2% quarterly fall. On an annual basis, GDP contracted 17.1% in the first quarter, versus the earlier estimate of a 6% year-on-year decrease.
Why modified domestic demand matters
Irish authorities rely on modified domestic demand as a gauge of underlying economic activity because the country’s sizeable multinational sector can skew headline GDP figures. The statistics office said modified domestic demand grew 4.3% year-over-year in Q1 and expanded 4.9% for the full year 2025.
Context from 2025 and revisions
GDP had surged 12.3% in 2025, driven by a substantial rise in pharmaceutical exports to the United States. That increase reflected firms stockpiling products ahead of possible tariffs and elevated demand for weight-loss drug ingredients manufactured in Ireland, the statistics office noted.
The office also revised its fourth-quarter GDP estimate, changing the previously reported 3.8% quarterly decline to a 4.2% drop. Fourth-quarter modified domestic demand figures were unchanged, at 1.0% quarter-on-quarter and 6.7% year-on-year.
Implications for euro zone metrics
The updated GDP reading has potential implications for how Ireland’s share of economic activity is calculated across the euro zone, since GDP remains the standard metric for such cross-country assessments.
Summary of points
- Modified domestic demand - intended to filter multinational distortions - rose 0.6% quarter-on-quarter in Q1 and 4.3% year-on-year.
- Headline GDP dropped 12.1% quarter-on-quarter and 17.1% year-on-year in Q1, both worse than earlier estimates.
- Previous-year GDP growth of 12.3% in 2025 was driven by increased pharmaceutical exports to the U.S., tied to stockpiling ahead of potential tariffs and high demand for weight-loss drug components.
Key points
- Measurement focus: Modified domestic demand is being used to assess domestic economic strength given multinational-driven volatility in GDP.
- Sector impact: Pharmaceutical exports played a material role in recent GDP swings, affecting headline national accounts.
- Statistical revisions: Q4 GDP was revised downward to a 4.2% quarterly fall, while related modified domestic demand figures for Q4 were unchanged.
Risks and uncertainties
- Volatility in headline GDP - Large multinational transactions can cause substantial swings in GDP, creating uncertainty for comparisons over short periods; this affects national and euro zone-level activity shares.
- Revision risk - The statistics office has revised recent quarterly GDP figures, indicating that headline measures may change as more information becomes available, which can influence policy or market assessments reliant on those figures.
- Concentration risk in exports - The outsized role of pharmaceutical exports in recent GDP movements implies that sector-specific shifts can disproportionately impact headline readings and related market perceptions.
Conclusion
The Central Statistics Office’s latest release presents a contrast between underlying domestic momentum and headline national accounts distorted by multinational activity. Modified domestic demand points to growth at home, while the large quarter-on-quarter GDP decline and subsequent revisions underline the volatility introduced by cross-border corporate activity and concentrated export flows.